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ABSTRACT
The presence of the methylated nucleobase
5MedC
in CpG islands is a key factor that determines gene
silencing. False methylation patterns are respon-
sible for deteriorated cellular development and are
a hallmark of many cancers. Today genes can be
sequenced for the content of
5MedC only with the
help of the bisulfite reagent, which is based exclu-
sively on chemical reactivity differences established
by the additional methyl group. Despite intensive
optimization of the bisulfite protocol, the method
still has specificity problems. Most importantly
 95% of the DNA analyte is degraded during the
analysis procedure. We discovered that the
reagent O-allylhydroxylamine is able to discriminate
between dC and
5MedC. The reagent, in contrast to
bisulfite, does not exploit reactivity differences but
gives directly different reaction products. The
reagent forms a stable mutagenic adduct with dC,
which can exist in two states (E versus Z). In case
of dC the allylhydroxylamine adduct switches
into the E-isomeric form, which generates dC
to dT transition mutations that can easily be
detected by established methods. Significantly, the
5MedC-adduct adopts exclusively the Z-isomeric
form, which causes the polymerase to stop.
O-allylhydroxylamine does allow differentiation
between dC and
5MedC with high accuracy, leading
towards a novel and mild chemistry for methylation
analysis.
INTRODUCTION
DNA methylation is an epigenetic mechanism for tran-
scriptional regulation (1–2). The process controls cellular
differentiation and is defective in many diseases including
cancer (3–5). DNA methylation involves substitution of
the H atom at C5 of the cytosine base (dC) by a methyl
group to give 5-methylcytosine (
5MedC) (6). These
methylated
5MedC bases trigger processes that ﬁnally
lead to gene silencing. Today, the detection of
5MedC
bases in a given DNA sequence is possible with restriction
enzymes, which cleave selectively unmethylated DNA (7),
or with antibodies, which recognize methylated DNA
(8–10). The current gold standard, however, is bisulﬁte
sequencing. This reagent selectively deaminates dC to
dU but does not affect
5MedC (11, 12). The position of
the newly formed dU base is then detected with standard
sequencing methods after PCR ampliﬁcation of the
treated DNA material (13). Bisulﬁte sequencing is cur-
rently in widespread use (14–18). However, during
bisulﬁte analysis  95% of the DNA material is
degraded, which limits
5MedC detection if only a small
amount of sample is available (19–21). This drawback
fuels current research to ﬁnd alternative
5MedC detection
and sequencing methods (22). Research in this direction
has furnished the result that Br
+ ions add selectively to
5MedC to give cleavable DNA sites (23). OsO4 and
reagents derived thereof were found to cis-hydroxylate
dC bases with some selectivity (24, 25). Furthermore
photochemical methods were reported (26, 27) that
allow some discrimination and ﬁnally even compounds
were reported that are added during bisulﬁte sequencing
to trap intermediates of the bisulﬁte reaction (28). All
reported approaches target the reactivity differences
between dC and
5MedC imposed by the additional
methyl group. However, as this difference is small, all
new procedures are currently unable to distinguish
between the dC and
5MedC efﬁciently or their general
approach interferes with current sequencing techniques.
Here we report a novel concept that does not rely on
reactivity differences but in contrast allows detection
of
5MedC directly based on the reaction product.
Incubation of dC and
5MedC with hydroxylamine deriva-
tives gives E- and Z-conﬁgured oxime-type adducts (Z/E-1
and Z/E-2, see Scheme 1) (29,30). The E- and
Z-conﬁgured products are in equilibrium via the amino
isomeric forms A-1 and A-2. Each of these isomers
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Whereas the amino tautomers (A) base pair like dC, the
E-isomers are expected to code like dT. The Z-isomers
likely cause stalling of polymerases during replication
(Scheme 1) because they interfere with normal base
pairing. NMR studies have shown that the pyrimidine
oximes like 1 and 2 are present mainly in the imino
tautomer and that the Z-isomers are the most stable
forms (31). In the case of
5MedC, we expected that the
isomer E-2 would be disfavored because of the steric
strain imposed between the methyl group and the O-allyl
chain. The
5MedC-adduct 2 should therefore prefer
Z-conﬁguration (Z-2) or exist in the amino tautomeric
form (A-2). As such, we expected that this product
would prefer base pairing with dG. In the case of the dC
adduct 1 steric strain with the hydrogen atom at C5 is
much lower and we hoped that this adduct would in
contrast adopt at least to some extent the E–conﬁguration,
which would allow base pairing with dATP. The resulting
dC to dT transition mutation we thought could be ex-
ploited as the desired signal that allows dC to be distin-
guished from
5MedC. As our approach is based on
mutagenicity, it is sequence independent and can also
detect methylated cytosines that are not in a CpG
context as found, for instance, in plant genomes. This is
an advantage over restriction enzyme based methods that
are limited by the speciﬁcity of the enzyme.
MATERIALS AND METHODS
Incubation of DNA strands
In a thermocycler (Eppendorf Mastercycler personal) with
a heatable lid a single-stranded oligodeoxynucleotide
ODN (10mM) (Metabion, Martinsried, Germany) was
incubated with NH2OAllyl (1M, pH 5.2 with HNEt2,
Fluka, Buchs, Switzerland) for 4h at 60 C. For incubation
kinetics 200pmol of the DNA were directly injected into a
HPLC without prior desalting (for detailed incubation
kinetics please refer to the Supplementary Data). If the
sample was to be sequenced it was desalted using
BioSpin 6 Tris columns (BioRad, Hercules, CA, USA)
that were previously equilibrated three times with 500ml
ddH2O. The ﬁltrate was concentrated in a SpeedVac
(Christ RVC-2-33 IR), re-dissolved in NH3 (28% in
H2O, Fluka, Buchs, Switzerland) and heated to 60 C for
90min in a thermocycler with a heatable lid. The solution
was again desalted using BioSpin 6 Tris columns. The
concentration of the solution was determined with a
NanoDrop photometer (PeqLab ND-1000). The treat-
ment with ammoniumhydroxide is optional but proved
to be beneﬁcial for the subsequent sequencing process
because it converts the bis-hydroxylamineadduct
(Supplementary Data) which is to a small extent formed
into the desired compound 1 in base promoted elimination
reaction.
Hybridization of DNA
An amount of 1.2mM ODN, 1mM primer and a suitable
buffer (NEBuffer 2, NEB, Frankfurt am Main, Germany)
were mixed and heated to 95 C for 4min in a thermocycler
with a heatable lid. The solution was allowed to cool at a
rate of 1 C per minute and stored at 4 C in the dark.
Direct sequencing
An amount of 10pmol dsDNA in 25ml Annealing Buffer
(Qiagen, Hilden, Germany) were sequenced in a
PyroMark Q24 Pyrosequencer. All bases except the
lesion generated by incubation were sequenced using
Scheme 1. Reaction of dC and
5MedC with hydroxylamine derivatives. Depiction of the tautomeric equilibrium and the interconversion process
between the Z-isomers and the E-isomers. 1: dC-O-allylhydroxylamine—adduct; 2:
5MedC–O–allylhydroxylamine—adduct.
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tides opposite the incubated dC or
5MedC is slower than
opposite canonical bases, addition of the nucleotide was
repeated 10 times. The data was analyzed by the software
provided by the manufacturer. The software sums up the
peak heights and determines the ratio of dATPaS/dGTP
incorporation. The last methylation site cannot be
detected, because the last position in a strand generally
yields no results in pyrosequencing. Please note that due
to the special pyrosequencing procedure dATPaS instead
of dATP was used.
Primer extension based sequencing
An amount of 10pmol of the incubated sample were
hybridized with a biotinylated primer. 0.1U/ml
Klenow(Exo-) polymerase, 500mM dNTPs and 1mM
dsDNA in 20ml1   NEB Buffer 2 were incubated for
10–60min at 60 C. To the solution were added 2ml
Streptavidin Sepharose beads (GE Healthcare, Uppsala,
Sweden), 40ml Binding Buffer (Qiagen) and 18ml ddH2O.
After agitation at 1400rpm for 15min the beads were
captured with a Vacuum Prep Tool (Qiagen), washed
with 70% EtOH, 0.1M NaOH and Washing Buffer
(Qiagen). The beads were dissolved in 25ml Annealing
Buffer (Qiagen) containing 10pmol sequencing primer
(Metabion). Pyrosequencing was performed on a
PyroMark Q24 Pyrosequencer using standard conditions
(Qiagen). The data was analyzed by the software provided
by the manufacturer. The average dTTP incorporation of
all experiments was calculated and the data plotted
relative to this value. Negative deviations from average
correspond to
5MedC, positive values to dC. The data
displayed are the average of three measurements.
Real-time primer extension based quantiﬁcation
ODN1C and ODN1M were mixed at different ratios,
incubated with NH2Oallyl and hybridized with ODN2 as
described earlier. In a 96-well plate (NUNC, Roskilde,
Denmark) were mixed per well: 10pmol dsDNA (10ml),
0.15U ATP sulfurylase (0.5ml), 1U Klenow(exo–) poly-
merase (0.2ml), 500pmol APS (1ml), 78.3ml ENLITEN
luciferase, luciferin reagent (Promega, Madison, WI,
USA). In a 96-well reader (TECAN Genios Pro) at 30 C
10ml dATPaS (20mM) were injected at 200ml/s. The plate
was shaken for 5s (amplitude 5mm) and the luminescence
measured every 250ms for 400 cycles. The data was col-
lected by the Microsoft Excel Makro provided by the
manufacturer. The average of four blank measurements
(enzymes without DNA) was subtracted from the
average of four measurements of the sample. The data
for dATPaS incorporation opposite undamaged dC was
taken as baseline. In the ﬁrst 15–20s the curves are
unstable due to mixing effects, so the data is only shown
from second 20 onwards. The slope of the curves shows
the speed of incorporation of dATPaS which corresponds
to the fraction of dC in the sample.
Protein puriﬁcation
The polymerase subunit of DNA polymerase I from
Geobacillus stearothermophilus (DSM No. 22) was
ampliﬁed via PCR and subcloned in pENTR-
TEV-D-TOPO (Invitrogen, Karlsbad, USA) to introduce
an N-terminal TEV-protease recognition site. The
fragment was then transferred to the expression plasmid
pDEST007 (32), yielding a cleavable N-terminal Strep-tag
II. The protein was expressed in Escherichia coli BL21 at
37 C by induction at OD600=1 with 0.2mg/l anhydrote-
tracycline for 2h. Cells were resuspended in 100mM Tris–
Cl pH 7.5, 150mM NaCl, 10mM ß-ME and Complete
protease inhibitor (Roche), lysed by French-press and
heated to 50 C for 10min to denature E. coli proteins.
0.1% NP-40 and Tween-20 were added to the lysate
prior to heat-treatment and maintained during Strep-tag
puriﬁcation. The cleared lysate was loaded on a
Streptactin column (IBA) and eluted with desthiobiotin.
Subsequently, the tag was cleaved by incubation on
ice with 10U/mg AcTEV protease (Invitrogen) over
night. Further puriﬁcation via Heparin afﬁnity chroma-
tography and crystallization was performed as described
in (33).
Co-crystallization
For co-crystallization the template containing lesion 1 was
annealed to the corresponding primer (for sequences see
Supplementary Data) in the protein storage buffer (10mM
Na–cacodylate pH 7, 50mM NaCl, 0.5mM EDTA
10mM MgSO4). Prior to crystallization protein and
DNA were mixed in a 1 to 3 molar ratio. The ﬁnal con-
centration of Pol I and dsDNA were 5mg/ml and 0.5mM,
respectively. Crystals were grown by mixing an equal
volume of protein-DNA complex with 47.5–51.0%
(NH4)2SO4, 3.0–3.5% MPD and 100mM MES pH 5.8,
using the hanging-drop vapor diffusion method. The crys-
tallization plates were incubated at 18 C and crystals
appeared after 1–2 days. Crystals were frozen in 24%
sucrose, 55% (NH4)2SO4, 3.0–3.5% MPD, 100mM
MES and stored in liquid nitrogen for data collection.
Best crystals were obtained with 49.5% (NH4)2SO4 and
3% MPD.
Collection and processing of X-ray diffraction data,
phase determination and structure reﬁnement
Data were collected at the beamline PXIII [Swiss Light
Source (SLS), Villigen, Switzerland] The data were pro-
cessed with the programs XDS (34) and SCALA (35, 36).
Structure solution was carried out by molecular
replacement with Phaser (37) using the coordinates
of 1U45 (38). In order to reduce model bias, the tem-
perature factors were reset to 20 for main chain and
40 for side chain and DNA atoms, respectively. Prior to
model building in COOT (39) a simulated annealing
omit map, removing the area around the lesion, was
calculated with PHENIX (40). Restrained reﬁnement was
carried out on REFMAC5 (41). Data processing and
reﬁnement statistics are summarized in Supplementary
Table S1.
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What are the coding properties of the DNA
lesions 1 and 2?
In order to investigate whether the dC-adduct 1 and
5MedC-adduct 2 have different coding properties we
reacted the oligodeoxynucleotide ODN1 (Figure 1A) con-
taining either a dC or a
5MedC (ODN1C and ODN1M)
with various hydroxylamine derivatives (10mM DNA, 1M
NH2OR, pH=5.2, 4h, 60 C). The best results were
ﬁnally obtained with O–allylhydroxylamine, which fur-
nished lesions 1 and 2 cleanly and in high yields
(Supplementary Data). We observed a small reactivity dif-
ference between dC and
5MedC, with the latter reacting
three to ﬁve times slower (42). Most importantly, no
DNA degradation or reaction with other DNA bases
was observed.
To investigate the coding properties of the reaction
products 1 and 2 we performed primer extension reactions
with the primer ODN2, Klenow(exo-) polymerase and
ODN1C or ODN1M (Figure 1A1–3). For both oligo-
nucleotides we observed full extension before and after
treatment with O-allylhydroxylamine. This proves that
the polymerase can indeed read through the
hydroxylamine adduct 1. When dGTP was removed
from the primer extension assay (Figure 1A3), we
observed that after incubation with O–allylhydroxylamine
only unmethylated ODN1C but not methylated ODN1M
was copied. This shows that adduct 1 is replicatively
bypassed and that it is base-paired with a triphosphate
other than dGTP. Further studies, depicted in
Figure 1B, showed that the polymerase is able to pair 1
with dATP. In order to investigate the relative incorpor-
ation efﬁciency of dATP and dGTP opposite 1 the primer
extension studies were repeated with dGTP replaced by
ddGTP (Figure 1A2). The data show that Klenow(exo-)
pairs 1 with dGTP and dATP with similar efﬁciencies.
Other polymerases tested including low ﬁdelity polymer-
ases such as Pol Z and Pol k showed the same behavior. In
the case of ODN1M we observed full extension only when
all four triphosphates are present (Figure 1A1). No elong-
ation was detected in the absence of dGTP, showing that
adduct 2 either only allows incorporation of dGTP or
blocks the polymerase. Further studies, shown in
Figure 1C, with ODN3 in which we synthetically
inserted the
5MedC adduct 2, conﬁrmed that bypass of
adduct 2 is indeed difﬁcult and not possible with dATP.
In summary, the results show that oxime 1 instructs a
polymerase to introduce dG and dA into the primer.
Adduct 2 in contrast hinders replication and instructs
the polymerase to incorporate a dG. Both adducts 1 and
2 consequently differ dramatically regarding their coding
characteristics, and only the adduct derived from dC gives
rise to dC to dT transition mutations, providing the
requested readout for epigenetic sequencing.
What is the structural basis of the different
coding properties?
In order to prove that the formation of a E-1:dA base pair
is the reason for the mutational bypass we crystallized a
duplex containing the base pair with the protein B.st Pol I
(38). The full structure is depicted Figure 2. It shows the
E-1:dA base pair determined at a resolution of 2.9A ˚ . The
O–allyl–hydroxylamine-dC adduct 1 is indeed present in
Figure 1. (A) Primer extension reactions of incubated (but not puriﬁed)
ODN1 with primer ODN2 [1U Klenow
(exo–),5 mM dNTP, 10min,
30 C]. ODN1C: X=dC, ODN1M:X =
5MedC, ODN1T: X=dT.
(A1) With all triphosphates present all strands are fully elongated
before and after treatment. (A2) With ddGTP instead of GTP
present, all strands are elongated by one base. After incubation with
O–allylhydroxylamine (red) only ODN1C but not ODN1M shows the
dC!dT transition mutation and is fully elongated. (A3) Without
dGTP again only ODN1C is elongated after O–allylhydroxylamine
treatment. (B) Primer extension reactions of analytically pure ODN3
with Primer ODN4 [1U Klenow
(exo–),5 0 mM dNTP, 30 C, 10min] of
ODN3 with X=dC and X=1. While dC can only base pair with
dGTP, 1 can induce incorporation of dATP, thus generating a C!
T transversion mutation. (C) Primer extension of analytically pure
ODN3 with X=1 and X=2 and primer ODN4 using dATP and
dGTP. [1U Klenow
(exo–), 1.5mM dNTP, 30 C, 10min]. ODN3 with
X=1 can be elongated with dATP and dGTP, while elongation of
the strand containing 2 is not possible.
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perfect Watson–Crick type H–bonds as expected.
Can the coding properties be exploited for a direct
readout of the methylation status?
In order to study if the coding difference of the dC and
5MedC oxime adducts 1 and 2 can be exploited for epigen-
etic sequencing, we analyzed the promoter sequence of the
cyclin-dependent kinase inhibitor gene p15, known to be
aberrantly methylated in acute myeloid leukemia patients
(43–45). For the study we used ODN5 (Figure 3A) con-
taining two either methylated or unmethylated CpG sites
and one dC site that does not neighbor a dG. After incu-
bation of ODN5 with O–allylhydroxylamine followed
by hybridization with a sequencing primer ODN6 the
three DNA constructs were directly subjected to
pyrosequencing, which visualizes elongation of the
primer strand (ODN6) by a luminescence signal (46).
The results for position 23 and 26 are depicted in
Figure 3B. As expected, both dC and
5MedC in untreated
oligonucleotides direct the addition of dGTP to the
primer. The treated DNA strands, in contrast, showed
signiﬁcant incorporation of dATP opposite the dC.
Opposite
5MedC this misincorporation was in all cases
not detected (<5% which is the error range of the instru-
ment, Figure 3B). Important is the ﬁnding that the
O–allylhydroxylamine modiﬁed dC base 1 instructs in-
corporation of  50% dATPaS regardless of the position
of the dC base, showing that no sequence effects occur.
Does the novel method allow sequencing of DNA
fragments usually employed in pyrosequencing?
We extended the new epigenetic sequencing possibility to
the analysis of a longer promoter sequence. For this ex-
periment we choose an 84-bp fragment with three either
methylated or unmethylated CpG sites (ODN7, CpG at
positions 23, 34 and 57, for sequence see Supplementary
Data) of the p15 promoter. Such a promoter sequence is a
typical target of bisulﬁte sequencing. For the experiment
(Figure 4A) we ﬁrst incubated the different 84–mer oligo-
nucleotides with O–allylhydroxylamine and subsequently
hybridized the treated strands with the biotinylated primer
ODN8, (for sequence see Supplementary Data). We next
performed the primer extension reaction with the
Klenow(exo-) polymerase and isolated the product DNA
strand via streptavidin-coated sepharose beads. Following
hybridization with the sequencing primer (ODN9, for
sequence see Supplementary Data) the obtained oligo-
nucleotides were ﬁnally analyzed via pyrosequencing.
The results are depicted in Figure 4B.
The sequencing data clearly furnished a dT signal at all
original dC positions in the promoter. The signal was in
Figure 2. Crystal structure of BstPolI in complex with a DNA double
strand containing a 1:dATP base pair (PDB: 2xo7). 2Fo–Fc electron
density for the base pair is depicted at the 1s level.
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Figure 3. (A) Fragment of the p15 promoter used for direct
sequencing. (B) Direct sequencing of ODN5 with primer ODN6;
Workﬂow: Incubation with NH2Oallyl converts dC to 1,
5MedC is to
a small extent converted to 2. 1 mispairs with dATPaS, while
5MedC
pairs with dGTP and 2 blocks. Note that position 31 cannot be
sequenced because pyrosequencing does not allow sequencing of the
last position.
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same signal intensities are obtained at all dC positions
showing again that sequence effects are negligible. The
O–allylhydroxylamine based epigenetic sequencing
method in the reported form is consequently only
limited by the pyrosequencing method, which currently
limits sequencing to <100- to 150-base long oligonucleo-
tides. As the result provides the same ﬁnal readout as
bisulﬁte sequencing it is fully compatible with current
epigenetic sequencing equipment.
Can the ratio of dC to
5MedC be determined in a sample?
Generally, the extent of the methylation can be
determined by comparing the relative heights of the dT
and dC signals as done in bisulﬁte sequencing.
Additionally, we aimed to develop an alternative
approach that is based on a real time primer extension
reaction. By coupling a polymerase to a luciferase, elong-
ation of a DNA strand can be monitored by light. In the
case of
5MedC no light upon addition of dATPaS can be
detected. If a mixture of dC and
5MedC is present the
amount of luminescence represents the fraction of dC in
the sample. As shown in Figure 5 the extent of methyla-
tion of a speciﬁc CpG site can be readily determined after
calibration.
Can the method distinguish between
5MedC and
5HOMedC?
Recently, 5-hydroxymethylcytosine (
5HOMedC) has been
found as a second post-replicatively formed DNA base
(47, 48). Newly developed methods allow for precise quan-
tiﬁcation of
5HOMedC levels in tissues, but do not yield
sequence-speciﬁc information (49). It is highly desired to
have a method that can distinguish
5HOMedC and
5HOMedC at a single base resolution. Unfortunately, as
the detection principle presented in this work is based on
sterics and the new base
5HOMedC even imposes a larger
steric strain it is not possible to distinguish
5MedC and
5HOMedC after incubation with O–allylhydroxylamine.
CONCLUSION
In conclusion, we show that the E/Z equilibrium of
O–allylhydroxylamine dC/
5MedC adducts is inﬂuenced
by the presence of a methyl group at C5. The lesion
generated from dC after O–allylhydroxylamine treatment
is bypassed by base pairing with dA and dG. In contrast,
after incubation of
5MedC only incorporation of dG can be
observed. This allows for the ﬁrst time detection of the
methylation status of a cytosine not only based on
reaction rates but based on different reaction products.
We used this observation to establish the ﬁrst bisulﬁte
Figure 4. Primer extension based sequencing of ODN7 in four different
methylation states, (A) Workﬂow: Incubation with NH2Oallyl converts
dC to 1,
5MedC is to a small extent converted to 2. 1 mispairs with
dATP, while
5MedC pairs with dGTP and 2 blocks. After primer
extension original dC is thus detected by a dT signal, while original
5MedC still only shows a dC signal. (B) Results of the measurements,
the deviation of dTTP incorporation from average is shown. Positive
values show umethylated, negative values show methylated cytosines.
For sequences of ODN 7–9 see Supplementary Data.
Figure 5. Real time primer extension based quantiﬁcation of the extent
of the methylation in ODN1. The slope of the curves shows the speed
of incorporation of dATPaS which corresponds to the fraction of dC in
the sample.
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5MedC sequencing principle. The selectivity of
the method is controlled by two chemical ﬁlters. First, dC
reacts faster with NH2Oallyl and secondly, only the dC
adduct 1 but not the
5MedC adduct 2 can induce dC to dT
transition mutations, which can be detected by standard
sequencing methods. As this is the same readout as for the
bisulﬁte method our system is fully compatible with
current sequencing equipment. The next focus in our
research will be to couple our novel detection principle
to modern sequencing-by-synthesis methods that could
allow our method to be routinely applied for the methy-
lation analysis of small amounts of DNA. Alternatively
one could imagine PCR based approaches that are
employed in bisulﬁte sequencing or to exploit the muta-
genic potential of hydroxylamines by subcloning in
bacteria.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online. The
crystal structure can be accessed under pdb code 2xo7.
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